Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 150374-99-5 Chemical Structure| 150374-99-5

Structure of 150374-99-5

Chemical Structure| 150374-99-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 150374-99-5 ]

CAS No. :150374-99-5
Formula : C11H13ClO4S
M.W : 276.74
SMILES Code : CC(C)(C)C(OC1=CC=C(S(=O)(Cl)=O)C=C1)=O
MDL No. :MFCD08274725
InChI Key :BSRSTUAZWZWGRT-UHFFFAOYSA-N
Pubchem ID :11011277

Safety of [ 150374-99-5 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H314
Precautionary Statements:P260-P280-P303+P361+P353-P301+P330+P331-P304+P340+P310-P305+P351+P338+P310
Class:8
UN#:3261
Packing Group:

Computational Chemistry of [ 150374-99-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 17
Num. arom. heavy atoms 6
Fraction Csp3 0.36
Num. rotatable bonds 4
Num. H-bond acceptors 4.0
Num. H-bond donors 0.0
Molar Refractivity 65.19
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

68.82 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.54
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.1
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.65
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.31
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.98
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.71

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.51
Solubility 0.0863 mg/ml ; 0.000312 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-4.21
Solubility 0.0169 mg/ml ; 0.0000612 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.84
Solubility 0.0404 mg/ml ; 0.000146 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

Yes
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.79 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<0.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.02

Application In Synthesis of [ 150374-99-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 150374-99-5 ]

[ 150374-99-5 ] Synthesis Path-Downstream   1~35

  • 1
  • [ 110-91-8 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-(morpholine-4-sulfonyl)-phenyl ester [ No CAS ]
  • 2
  • [ 288-32-4 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-(imidazole-1-sulfonyl)-phenyl ester [ No CAS ]
  • 3
  • [ 5344-90-1 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-(2-hydroxymethyl-phenylsulfamoyl)-phenyl ester [ No CAS ]
  • 4
  • [ 119-68-6 ]
  • [ 150374-99-5 ]
  • [ 188115-02-8 ]
  • 5
  • [ 19008-43-6 ]
  • [ 150374-99-5 ]
  • 4-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-benzoic acid benzyl ester [ No CAS ]
  • 6
  • [ 6303-99-7 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-[2-(2-carboxy-ethoxy)-phenylsulfamoyl]-phenyl ester [ No CAS ]
  • 7
  • [ 82185-41-9 ]
  • [ 150374-99-5 ]
  • 2-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-benzoic acid benzyl ester [ No CAS ]
  • 8
  • [ 156674-65-6 ]
  • [ 150374-99-5 ]
  • 4-{2-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-phenoxy}-butyric acid [ No CAS ]
  • 9
  • [ 80787-43-5 ]
  • [ 150374-99-5 ]
  • 3-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-benzoic acid benzyl ester [ No CAS ]
  • 10
  • [ 112626-34-3 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-{2-[(carboxymethyl-carbamoyl)-methyl]-phenylsulfamoyl}-phenyl ester [ No CAS ]
  • 11
  • [ 75-64-9 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-tert-butylsulfamoyl-phenyl ester [ No CAS ]
  • 12
  • [ 100-61-8 ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-(methyl-phenyl-sulfamoyl)-phenyl ester [ No CAS ]
  • 13
  • (2S)-N-(o-aminobenzoyl)-2-methylaminoacetic acid [ No CAS ]
  • [ 150374-99-5 ]
  • 2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-methyl-carbamoyl)-phenylsulfamoyl]-phenyl ester [ No CAS ]
  • 14
  • [ 150374-99-5 ]
  • 1-(2-Amino-benzoyl)-piperidine-4-carboxylic acid [ No CAS ]
  • 1-{2-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-benzoyl}-piperidine-4-carboxylic acid [ No CAS ]
  • 15
  • [ 150374-99-5 ]
  • (4-Amino-benzoylamino)-acetic acid benzyl ester [ No CAS ]
  • 2,2-Dimethyl-propionic acid 4-[4-(benzyloxycarbonylmethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester [ No CAS ]
  • 16
  • [ 150374-99-5 ]
  • benzyl 2-(2-aminobenzamido)acetate [ No CAS ]
  • [ 150374-98-4 ]
YieldReaction ConditionsOperation in experiment
89.5% With pyridine; In dichloromethane; at 20 - 25℃; for 3.5h; Benzyl 2- (2-aminobenzamido) acetate (10) (1.4 g, 0.0049 mol) prepared according to Example 8 was dissolved in dichloromethane (9 ml) and pyridine(1.2 g, 0.015 mol)Of the suspension,4- (chlorosulfonyl) phenyl (6) pivalate prepared according to Example 4(1.4 g, 0.0049 mol) in dichloromethane (7 ml)At 20 to 25 C. in about 30 minutes. The mixtureWhile monitoring by HPLC,Stirring is continued for 3 hours. After completion of the reaction,Water (10 ml) was added,Separate the phases. The organic phase was washed with waternext,Wash with 10% hydrochloric acid (10 ml) and saturated aqueous NaCl solution (10 ml). The mixture was crystallized from isopropyl ether (10 ml)Filtered,Dry at 40 C under reduced pressure. 2.3 g (89.5%) of a white solid are obtained.
  • 17
  • [ 150374-99-5 ]
  • (3-Amino-benzoylamino)-acetic acid benzyl ester [ No CAS ]
  • 2,2-Dimethyl-propionic acid 4-[3-(benzyloxycarbonylmethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester [ No CAS ]
  • 18
  • [ 150374-99-5 ]
  • 4-(2-Amino-benzoylamino)-butyric acid benzyl ester [ No CAS ]
  • 4-{2-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-benzoylamino}-butyric acid benzyl ester [ No CAS ]
  • 19
  • [ 150374-99-5 ]
  • 3-(2-Amino-benzoylamino)-propionic acid benzyl ester [ No CAS ]
  • 2,2-Dimethyl-propionic acid 4-[2-(2-benzyloxycarbonyl-ethylcarbamoyl)-phenylsulfamoyl]-phenyl ester [ No CAS ]
  • 20
  • [ 150374-99-5 ]
  • 6-(2-Amino-benzoylamino)-hexanoic acid benzyl ester [ No CAS ]
  • 6-{2-[4-(2,2-Dimethyl-propionyloxy)-benzenesulfonylamino]-benzoylamino}-hexanoic acid benzyl ester [ No CAS ]
  • 21
  • p-pivaloyloxybenzenesulfonic acid sodium salt [ No CAS ]
  • [ 150374-99-5 ]
YieldReaction ConditionsOperation in experiment
81.6% With thionyl chloride; In N,N-dimethyl-formamide; at 5 - 20℃; for 1.5h; (5) (1.5 g, 0.0054 mol) of 4- (pivaloyloxy) benzenesulfonate prepared according to Example 1,(0.78 g, 0.0065 mol) in DMF (7 ml) is added dropwise over 5 min at 0-5 C. The mixture is monitored by HPLC and the reaction is carried out at this temperature After completion of the reaction, water (10 ml) was added, and the mixture was filtered, washed thoroughly with water, and then dried under reduced pressure at 16 C. for 15 minutes at 45 C. The reaction mixture was stirred for 1 hour, Drying over time gives 1.2 g (81.6%) of a white solid.
  • 22
  • [ 98-52-2 ]
  • [ 150374-99-5 ]
  • 4-tert-butylcyclohexyl p-pivaloyloxybenzenesulfonate [ No CAS ]
  • 23
  • [ 57-88-5 ]
  • [ 150374-99-5 ]
  • 5-cholesten-3β-yl (p-pivaloyloxybenzenesulfonate) [ No CAS ]
  • 24
  • [ 150374-99-5 ]
  • [ 582-52-5 ]
  • 1,2:5,6-di-O-isopropylidene-3-O-(p-pivaloyloxybenzenesulfonyl)-α-D-glucofuranose [ No CAS ]
  • 25
  • [ 150374-99-5 ]
  • (+)-N-benzyloxy-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-7-carboxamide hydrochloride [ No CAS ]
  • (+)-N-benzyloxy-6-(4-pivaloyloxybenzenesulfonyl)-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-7-carboxamide [ No CAS ]
  • 26
  • [ 150374-99-5 ]
  • {(3aR,5R,6S,6aR)-2,2-Dimethyl-6-[((Z)-propenyl)oxy]-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl}-methanol [ No CAS ]
  • 1,2-O-isopropylidene-5-O-(p-pivaloyloxyphenylsulfonyl)-3-O-(prop-1'-enyl)-α-D-xylofuranose [ No CAS ]
  • 27
  • [ 150374-99-5 ]
  • [ 43138-65-4 ]
  • 1,2-O-isopropylidene-3-O-methyl-6-O-(p-pivaloyloxyphenylsulfonyl)-α-D-glucofuranose [ No CAS ]
  • 28
  • [ 150374-99-5 ]
  • [ 473734-65-5 ]
  • 1,2-O-isopropylidene-3-O-methyl-6-O-(p-pivaloyloxyphenylsulfonyl)-5-O-(prop-1'-enyl)-α-D-glucofuranose [ No CAS ]
  • 29
  • [ 150374-99-5 ]
  • 5-O-(p-hydroxyphenylsulfonyl)-1,2-O-isopropylidene-3-O-(prop-1'-enyl)-α-D-xylofuranose [ No CAS ]
  • 30
  • [ 150374-99-5 ]
  • 5-O-(p-tert-butyldimethylsilyloxyphenylsulfonyl)-1,2-O-isopropylidene-3-O-(prop-1'-enyl)-α-D-xylofuranose [ No CAS ]
  • 31
  • [ 150374-99-5 ]
  • (3'R,4'S)-5-O-(p-hydroxyphenylsulfonyl)-1,2-O-isopropylidene-3-O-(3'-methyl-2'-oxoazetidin-4'-yl)-α-D-xylofuranose [ No CAS ]
  • 32
  • [ 150374-99-5 ]
  • (3'S,4'R)-5-O-(p-hydroxyphenylsulfonyl)-1,2-O-isopropylidene-3-O-(3'-methyl-2'-oxoazetidin-4'-yl)-α-D-xylofuranose [ No CAS ]
  • 33
  • [ 150374-99-5 ]
  • (3'R,4'S)-1,2-O-isopropylidene-3-O-(3'-methyl-2'-oxoazetidin-4'-yl)-5-O-(p-pivaloyloxyphenylsulfonyl)-α-D-xylofuranose [ No CAS ]
  • 34
  • [ 150374-99-5 ]
  • (3'S,4'R)-1,2-O-isopropylidene-3-O-(3'-methyl-2'-oxoazetidin-4'-yl)-5-O-(p-pivaloyloxyphenylsulfonyl)-α-D-xylofuranose [ No CAS ]
  • 35
  • [ 150374-99-5 ]
  • (3'R,4'S)-5-O-(p-tert-butyldimethylsilyloxyphenylsulfonyl)-1,2-O-isopropylidene-3-O-(3'-methyl-2'-oxoazetidin-4'-yl)-α-D-xylofuranose [ No CAS ]
 

Historical Records

Technical Information

Categories